In a report released today, Joanne Wuensch from Citi maintained a Buy rating on Becton Dickinson (BDX – Research Report). The company’s shares ...

Becton Dickinson (BDX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Travis Steed ...

The BD Accuri™ C6 is a personal flow cytometer that brings flow cytometry within reach by being easy to use, simple to maintain, and affordable. The analytical power and versatility of today’s ...

Link: https://www.zacks.com/commentary/2382578/4-stocks-to-watch-amid-dental-supplies-industry-challenges The Zacks Medical - Dental Supplies industry in the Medical ...

Inspectors found 111 open tickets for software defects categorized as catastrophic or severe patient harm. Several safety ...

After hours: December 27 at 6:40:00 PM EST ...

16, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today ...

Copyright © 2024 MarketWatch, Inc. All rights reserved.

in which BD operates, continues to evolve rapidly. Analysts maintain a positive industry view, particularly for the U.S. Medical (TASE:PMCN) Supplies & Devices sector. This favorable outlook ...

The medical technology sector, in which BD operates, continues to evolve rapidly. Analysts maintain a positive industry view, particularly for the U.S. Medical (TASE:PMCN) Supplies & Devices sector.